Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Select Drug Profiles
NIH Research Funding Cuts Would Have Devastating Impact on Hematology
Wayne Kuznar
Read More
Leukemia
,
Oncology
Alternatives to “7 + 3” Induction Therapy for AML Are Emerging
Wayne Kuznar
Read More
Leukemia
,
Oncology
Fast Response Identifies Patients with CML for Entry into Studies of Imatinib Discontinuation
Wayne Kuznar
Read More
Leukemia
,
Oncology
“Dramatic” Responses with Targeted Agent for Patients with CLL
Charles Bankhead
Read More
Leukemia
,
Oncology
New Oral TKI Ponatinib Produces High Response Rates in Hard-to-Treat Leukemia
Wayne Kuznar
Read More
Rivaroxaban More Cost-Effective than Warfarin for Recurrent VTE Prevention
Caroline Helwick
Read More
Costs of Second-Line Metastatic Colorectal Cancer Treatments Compared
Caroline Helwick
Read More
Combined Chemoradiation Cost-Effective in Younger Patients with Primary CNS Lymphoma
Wayne Kuznar
Read More
Rasburicase Cost-Effective for Tumor Lysis Syndrome
Caroline Helwick
Read More
Internet-Based Tool Helps Guide Treatment Decisions in Patients with CML
Read More
181
182
183
184
185
186
187
Page 184 of 244
Results 1831 - 1840 of 2438
